{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:46:36Z","timestamp":1761237996050,"version":"3.37.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1124\/jpet.113.203554","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T06:26:25Z","timestamp":1368858385000},"page":"241-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models"],"prefix":"10.1016","volume":"346","author":[{"given":"M.T.","family":"Pulido-Rios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Obedencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jaw-Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.203554_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1476-5381.1990.tb12091.x","article-title":"Evidence for prejunctional M2 muscarinic receptors in pulmonary cholinergic nerves in the rat","volume":"101","author":"Aas","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.203554_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder","volume":"148","author":"Abrams","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.203554_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1152\/physrev.1992.72.3.699","article-title":"Modulation of neurotransmission in airways","volume":"72","author":"Barnes","year":"1992","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.113.203554_bib4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0024-3205(93)90310-Y","article-title":"Muscarinic receptor subtypes in airways","volume":"52","author":"Barnes","year":"1993","journal-title":"Life Sci"},{"issue":"2, Suppl","key":"10.1124\/jpet.113.203554_bib5","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1378\/chest.117.2_suppl.63S","article-title":"The pharmacological properties of tiotropium","volume":"117","author":"Barnes","year":"2000","journal-title":"Chest"},{"issue":"Suppl 12A","key":"10.1124\/jpet.113.203554_bib6","first-page":"24S","article-title":"The role of anticholinergics in chronic obstructive pulmonary disease","volume":"117","author":"Barnes","year":"2004","journal-title":"Am J Med"},{"key":"10.1124\/jpet.113.203554_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thx.2006.063271","article-title":"Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis","volume":"61","author":"Barr","year":"2006","journal-title":"Thorax"},{"key":"10.1124\/jpet.113.203554_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(87)90201-9","article-title":"A muscarinic receptor with high affinity for pirenzepine mediates vagally induced bronchoconstriction","volume":"133","author":"Bloom","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.203554_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1183\/09059180.00009902","article-title":"Reducing cholinergic constriction: the major reversible mechanism in COPD","volume":"15","author":"Brusasco","year":"2006","journal-title":"European Respiratory Review"},{"key":"10.1124\/jpet.113.203554_bib10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1378\/chest.118.5.1294","article-title":"The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial","volume":"118","author":"Casaburi","year":"2000","journal-title":"Chest"},{"key":"10.1124\/jpet.113.203554_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.203554_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/jpet.109.152470","article-title":"Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs","volume":"330","author":"Casarosa","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"year":"2004","series-title":"Pharmacotherapy in chronic obstructive pulmonary disease","author":"Celli","key":"10.1124\/jpet.113.203554_bib13"},{"key":"10.1124\/jpet.113.203554_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0024-3205(93)90312-Q","article-title":"Ba 679 BR, a novel long-acting anticholinergic bronchodilator","volume":"52","author":"Disse","year":"1993","journal-title":"Life Sci"},{"key":"10.1124\/jpet.113.203554_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0031-6997(25)06957-1","article-title":"Muscarinic receptor subtypes and smooth muscle function","volume":"48","author":"Eglen","year":"1996","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.113.203554_bib16","first-page":"L101","article-title":"Expression of muscarinic receptor subtypes and M2-muscarinic inhibition of adenylyl cyclase in lung","volume":"268","author":"Emala","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.203554_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/jpet.109.151639","article-title":"Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile","volume":"331","author":"Gavald\u00e0","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.203554_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3565(25)21361-1","article-title":"Characterization of muscarinic receptors in human, guinea pig and rat lung","volume":"250","author":"Gies","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.203554_bib19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1378\/chest.96.5.984","article-title":"Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects","volume":"96","author":"Gross","year":"1989","journal-title":"Chest"},{"key":"10.1124\/jpet.113.203554_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0026-895X(25)10204-6","article-title":"Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping","volume":"45","author":"Haddad","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.113.203554_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjp.0702573","article-title":"Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways","volume":"127","author":"Haddad","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.203554_bib22","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1378\/chest.128.4.1974","article-title":"Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma","volume":"128","author":"Hansel","year":"2005","journal-title":"Chest"},{"key":"10.1124\/jpet.113.203554_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0024-3205(98)00586-4","article-title":"Role of M2 muscarinic receptors in airway smooth muscle contraction","volume":"64","author":"Hirshman","year":"1999","journal-title":"Life Sci"},{"key":"10.1124\/jpet.113.203554_bib24","first-page":"L304","article-title":"Pre- and postjunctional muscarinic receptors in canine bronchi","volume":"259","author":"Janssen","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.203554_bib25","first-page":"1845","article-title":"Principles of nebulizer-delivered drug therapy for asthma","volume":"46","author":"Johnson","year":"1989","journal-title":"Am J Hosp Pharm"},{"key":"10.1124\/jpet.113.203554_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/adc.88.10.911","article-title":"A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling","volume":"88","author":"Jongerius","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1124\/jpet.113.203554_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/COPD.S4802","article-title":"Tiotropium HandiHaler in the treatment of COPD: a safety review","volume":"4","author":"Kesten","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1124\/jpet.113.203554_bib28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1378\/chest.130.6.1695","article-title":"Pooled clinical trial analysis of tiotropium safety","volume":"130","author":"Kesten","year":"2006","journal-title":"Chest"},{"key":"10.1124\/jpet.113.203554_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinthera.2005.04.006","article-title":"Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease","volume":"27","author":"Koumis","year":"2005","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.113.203554_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/bdd.280","article-title":"Pharmacokinetics and tissue distribution of the anticholinergics tiotropium and ipratropium in the rat and dog","volume":"22","author":"Leusch","year":"2001","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/jpet.113.203554_bib31","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1164\/ajrccm.161.4.9903044","article-title":"Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease","volume":"161","author":"Littner","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.203554_bib32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1183\/09031936.06.00126005","article-title":"An oral selective M3 cholinergic receptor antagonist in COPD","volume":"28","author":"Lu","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.203554_bib33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1183\/09031936.93.06071031","article-title":"Ba 679 Br, a new long-acting antimuscarinic bronchodilator: a pilot dose-escalation study in COPD","volume":"6","author":"Maesen","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.203554_bib34","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1183\/09031936.95.08091506","article-title":"Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD)","volume":"8","author":"Maesen","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.203554_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.vascn.2010.05.016","article-title":"Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents","volume":"63","author":"McNamara","year":"2011","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.113.203554_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2008.12.043","article-title":"Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist","volume":"605","author":"McNamara","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.203554_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/COPD.S3530","article-title":"Safety, tolerability and risk benefit analysis of tiotropium in COPD","volume":"3","author":"Oba","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1124\/jpet.113.203554_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1254\/jphs.10311FP","article-title":"Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate","volume":"115","author":"Ogoda","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.113.203554_bib39","unstructured":"Potgieter P, Hopkins A, Liu P, Quinn C, Amburgey C, and Moran E (2012) A randomized, crossover study to examine the pharmacodynamics and safety of a new antimuscarinic (TD-4208) in COPD. European Respiratory Society Annual Congress 2012. 9-5-2012. 9-1-9012."},{"key":"10.1124\/jpet.113.203554_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-147-9-200711060-00008","article-title":"Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians","volume":"147","author":"Qaseem","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.113.203554_bib41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.203554_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.archoralbio.2007.07.012","article-title":"Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man","volume":"53","author":"Ryberg","year":"2008","journal-title":"Arch Oral Biol"},{"key":"10.1124\/jpet.113.203554_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0773.1994.tb01070.x","article-title":"The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor, and salivation in male mice","volume":"74","author":"S\u00e1nchez","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/jpet.113.203554_bib44","doi-asserted-by":"crossref","first-page":"L1125","DOI":"10.1152\/ajplung.00084.2002","article-title":"Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus","volume":"283","author":"Sarria","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.113.203554_bib45","series-title":"The laboratory rat","first-page":"323","article-title":"Respiration","author":"Schulz","year":"2000"},{"key":"10.1124\/jpet.113.203554_bib46","first-page":"A4553","article-title":"In vitro characterization of TD-4208, a lung-selective and long-acting muscarinic antagonist bronchodilator (Abstract)","volume":"179","author":"Steinfeld","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.203554_bib47","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.113.203554_bib48","unstructured":"(2003) Tiotropium NDA-21-395. FDA CDER Tiotropium NDA-21-395. Pharmacol Rev 021395 (S-000 Part 01): https:\/\/www.pharmapendium.com\/fda.do?drugName=Tiotropium+Bromide+Monohydrate Accessed April 10, 2013."},{"key":"10.1124\/jpet.113.203554_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.55.4.289","article-title":"A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease","volume":"55","author":"van Noord","year":"2000","journal-title":"Thorax"},{"key":"10.1124\/jpet.113.203554_bib50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1183\/09031936.02.00238002","article-title":"Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease","volume":"19","author":"van Noord","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.203554_bib51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.203554_bib52","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1183\/09031936.00082507","article-title":"Definition, epidemiology and natural history of COPD","volume":"30","author":"Viegi","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.203554_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"Improved health outcomes in patients with COPD during 1 yr\u2019s treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.203554_bib54","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.pupt.2010.04.005","article-title":"Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients","volume":"23","author":"Vogelmeier","year":"2010","journal-title":"Pulm Pharmacol Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524287127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524287127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.203554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:15:14Z","timestamp":1739996114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524287127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0022356524287127"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.203554","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vivo Pharmacological Characterization of TD-4208, a Novel Lung-Selective Inhaled Muscarinic Antagonist with Sustained Bronchoprotective Effect in Experimental Animal Models","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.203554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}